11.3.2025 23:47:17 CET | Aqua Bio Technology ASA | Additional regulated information required to be disclosed under the laws of a member state

Reference is made to the announcement by Aqua Bio Technology ASA on 11 March 2025 concerning the successful placement of the conditional private placement with total gross proceeds of approximately NOK 24.2 million, and a contemplated subsequent offering (the " Subsequent Offering ").

Key information for the Subsequent Offering is set out below:

 Date on which the terms of the Subsequent        11 March 2025

 Offering was announced:

 Last day including right:                                           11 March 2025

 First day excluding right:                                          12 March 2025

 Record date:                                                               13 March 2025

 EGM date:                                                                   On or about 8 April 2025 (to be summoned)

 Maximum number of new shares:                         20,000,000

 Subscription price:                                                   NOK 0.50

 Shall the rights be listed                                          No

The issuance of new shares in the Subsequent Offering will be subject to approval of the pertaining share capital increase by the EGM to be held on or about 4 April 2025. The Board will assess the appropriate size of the Subsequent Offering and announce the final number of Offer Shares to be offered shortly prior to launch of the Subsequent Offering. The Subsequent Offering is expected to be carried out during the notice period for the EGM, with a one-week subscription period, expected to expire at least three days prior to the date of the EGM.

The new shares in the Subsequent Offering will initially be delivered on a separate ISIN as the listing of such new shares requires the preparation and publication of a prospectus approved by the Norwegian Financial Supervisory Authority.

This information is published in accordance with the requirements of the Continuing Obligations in Euronext Rule Book II.

Disclosure regulation

This information is subject of the disclosure requirements pursuant to section of 5-12 of the Norwegian Securities Trading Act.

Contacts

Fredrik Henriksen, CEO, Aqua Bio Technology ASA, +47 90 02 00 78, fredrik.henriksen@aquabiotech.no

About Aqua Bio Technology ASA

Aqua Bio Technology ASA (ABT) is a distribution group in skincare and nonfood. The group has distribution towards B2C, B2B, B2B2, and freight, customs, and logistics services. The group also develops sustainable biotechnology for use in skincare products. Aqua Bio Technology is listed on the Euronext Expand market of the Oslo Stock Exchange.

Attachments

Download announcement as PDF.pdf